Margaret Dugan

Margaret Dugan

Chief Tech/Sci/R&D Officer at SCHRÖDINGER, INC.

Net worth: 201 895 $ as of 2024-04-29

67 year
Health Technology
Consumer Services
Process Industries

Profile

Dr. Margaret H.
Dugan, MD, is a Chief Medical Officer at Schrödinger, Inc., an Independent Non-Executive Director at BeiGene Ltd.
and a Chief Medical Officer at Dracen Pharmaceuticals, Inc. She is on the Board of Directors at BeiGene Ltd.
Dr. Dugan was previously employed as a Senior VP & Head-Global Program Oncology by Novartis Pharmaceuticals Corp., a Director-Oncology Clinical Research by Schering-Plough Corp., and a Deputy Director-Clinical Research Oncology by Wyeth Holdings LLC.
She received her undergraduate degree from New York University and a doctorate degree from New York University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-04-18 16,692 ( 0.00% ) 201 895 $ 2024-04-29

Margaret Dugan active positions

CompaniesPositionStart
BEIGENE, LTD. Director/Board Member 2022-01-31
SCHRÖDINGER, INC. Chief Tech/Sci/R&D Officer 2022-12-31
Chief Tech/Sci/R&D Officer -
All active positions of Margaret Dugan

Former positions of Margaret Dugan

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Margaret Dugan's experience

Training of Margaret Dugan

New York University Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Margaret Dugan's experience

Connections

96

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BEIGENE, LTD.

Health Technology

SCHRÖDINGER, INC.

Technology Services

Private companies4

Health Technology

Health Technology

Process Industries

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Margaret Dugan